195 related articles for article (PubMed ID: 3978633)
21. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
Ross W; Rowe T; Glisson B; Yalowich J; Liu L
Cancer Res; 1984 Dec; 44(12 Pt 1):5857-60. PubMed ID: 6094001
[TBL] [Abstract][Full Text] [Related]
22. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
[TBL] [Abstract][Full Text] [Related]
23. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
Slater LM; Murray SL; Wetzel MW; Sweet P; Stupecky M
Cancer Chemother Pharmacol; 1986; 16(1):50-4. PubMed ID: 3455667
[TBL] [Abstract][Full Text] [Related]
24. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
Kerrigan D; Pommier Y; Kohn KW
NCI Monogr; 1987; (4):117-21. PubMed ID: 3041238
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
Maca RD
Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
[TBL] [Abstract][Full Text] [Related]
26. Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.
Glisson B; Gupta R; Smallwood-Kentro S; Ross W
Cancer Res; 1986 Apr; 46(4 Pt 2):1934-8. PubMed ID: 3004711
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression.
Hashimoto H; Chatterjee S; Berger NA
Cancer Res; 1995 Sep; 55(18):4029-35. PubMed ID: 7664276
[TBL] [Abstract][Full Text] [Related]
28. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.
Lorico A; Rappa G; Srimatkandada S; Catapano CV; Fernandes DJ; Germino JF; Sartorelli AC
Cancer Res; 1995 Oct; 55(19):4352-60. PubMed ID: 7671247
[TBL] [Abstract][Full Text] [Related]
29. Dipyridamole enhancement of etoposide sensitivity.
Howell SB; Hom DK; Sanga R; Vick JS; Chan TC
Cancer Res; 1989 Aug; 49(15):4147-53. PubMed ID: 2545335
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole.
Howell SB; Hom D; Sanga R; Vick JS; Abramson IS
Cancer Res; 1989 Jun; 49(12):3178-83. PubMed ID: 2720673
[TBL] [Abstract][Full Text] [Related]
31. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC
Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological activity of galactopyranoside derivatives of 4'-demethylepipodophyllotoxin showing VP-16 (etoposide)-like activity.
Pamidi CC; Derry WB; Gupta RS
Anticancer Drug Des; 1991 Nov; 6(5):481-93. PubMed ID: 1764166
[TBL] [Abstract][Full Text] [Related]
33. [Antitumor effect of etoposide and its analogs].
Kuramochi H; Okamoto K; Nishikawa K; Nagamine S; Takahashi K
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2196-201. PubMed ID: 4062319
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
35. [Effects of 4-(4"-(2",2",6",6"-tetramethyl-1"-pipe-ridinyloxy) amino)-4'-demethylepipodophyllotoxin on nucleic acids, proteins, and DNA strand of L7712 cells in vitro].
He XQ; Zhang PY; Tian X; Li JX
Zhongguo Yao Li Xue Bao; 1992 May; 13(3):276-9. PubMed ID: 1442115
[TBL] [Abstract][Full Text] [Related]
36. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
Yin MB; Bankusli I; Frank C; Rustum YM
Anticancer Res; 1990; 10(2A):327-32. PubMed ID: 2346306
[TBL] [Abstract][Full Text] [Related]
37. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
38. Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments.
Jensen PB; Sørensen BS; Sehested M; Grue P; Demant EJ; Hansen HH
Cancer Res; 1994 Jun; 54(11):2959-63. PubMed ID: 8187081
[TBL] [Abstract][Full Text] [Related]
39. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
40. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts.
Kalwinsky DK; Look AT; Ducore J; Fridland A
Cancer Res; 1983 Apr; 43(4):1592-7. PubMed ID: 6572554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]